Conformis Cordera Hip System Cleared

The FDA has granted 510(k) marketing clearance to Conformis for its Cordera total hip replacement system.

The system is cleared for use in hip replacements due to severely painful or disabled joints caused by arthritis and other conditions, such as vascular necrosis or congenital hip dysplasia.

The hip replacement system can also be used in revision procedures for failed previous hip surgery except where hardware is present, the company said.